Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Germany
since 2007 – Director, Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Germany
since 2007 – Full Professor (Cardiology/Adult Congenital Heart Disease), University of Muenster, Germany
1993 – 2007 Staff cardiologist, Dept. of Cardiology, Medical University – Vienna General Hospital
1993 – 2007 Professor of Medicine / Cardiology, Medical University of Vienna
1993 – 2007 Director, Adult Congenital Heart Disease and Acquired Valvular Heart Disease Program, Medical University of Vienna
1993 – 2007 Director, Research Program on Adult Congenital Heart Disease and Acquired Valvular Heart Disease, Medical University of Vienna
1993 – 2007 Director, In-Vitro Echocardiography Research Laboratory
1993 – 2001 Director, Echocardiography Laboratory, Dept. of Cardiology, Medical University of Vienna
1992 – 1993 Staff cardiologist and Director, Echocardiography Laboratory, 2nd Department of Internal Medicine / Cardiology, Krankenhaus der Barmherzigen Schwestern, Linz, Austria
1981 – 1983 Internship, Krankenhaus der Barmherzigen Schwestern , Linz and St. Pölten General Hospital, Austria
1994 – 1989 Residency/Fellowship, Internal Medicine; 1st and 2nd Dept. of Internal Medicine, Krankenhaus der Barmherzigen Schwestern, Linz, Austria
1989 – 1990 Research Fellowship, Division of Cardiology, Cedars-Sinai Medical Center, University of California at Los Angeles, Los Angeles, USA
1990 – 1991 Clinical Fellowship in Cardiology; 2nd Dept. of Internal Medicine / Cardiology, Krankenhaus der Barmherzigen Schwestern, Linz, Austria
Clinical and basic research in the area of valvular heart disease and congenital heart disease
Clinical and experimental research in echocardiography
Catheter intervention in congenital and acquired valvular heart disease Myocardial viability
More than 250 publications, of these more than 150 papers in peer-reviewed journals
Medical Societies / Fellowships / Journals (selected)
Austrian Society of Cardiology: Chairman of the working group on adult congenital heart disease; President of the Society 2005-2007
European Society of Cardiology: Board member 2006-2008; Nucleus member of the working group on grown-up congenital heart disease, co-chairman 2004-2006, chairman 2006–2008, past-chairman 2008-2010, Chairman, TF Practice guidelines on the management of grown-up congenital heart disease, Task forces and committees (Practice guidelines on the management of valvular heart disease, Education committee, Accreditation committee), Clinical Practice Guidelines Committee (2010-2014),Congress Programme Committee (2010-2014)
Arrhythmia and Electrophysiology Research Center, IRCCS Humanitas Research Hospital, Milan, Italy
Dr. Cappato received his degree in medicine from the University of Ferrara in 1983 and he was co-director of the EP-Lab at Eppendorf University and St. Georg General Hospital, Hamburg (Germany) between 1993 and 2000. He is experienced in the management of supraventricular and ventricular arrhythmias and in their treatment with trans-catheter radiofrequency ablation. He is a fellow of the European Society of Cardiology and the Heart Rhythm Society. He is the current President of the European Cardiac Arrhythmia Society (ECAS) and co-director of the Europe AF Congress since 2007. Dr. Cappato is a patent inventor of the Subcutaneous ICD developed by Cameron Health. He is principal investigator of X-Vert (exploring the efficacy and safety of once-daily oral rivaroxaban for the prevention of cardiovascular events in subjects with nonvalvular AF scheduled for cardioversion), VENTURE AF ablation study, chief investigator of Optimise (Omacor plus standard therapies in port MI subjects evaluation) and leading investigator of a patient-based worldwide AF ablation survey. He has published more than 300 peer reviewed manuscripts and book chapters and is on the editorial board of several Cardiology Journals. Frequently he serves as invited lecturer in major international scientific meetings.
Heart Hospital, London, UK
Professor Deanfield undertook his undergraduate medical training at Churchill College, Cambridge University, and subsequently at The Middlesex Hospital, London. He then trained at The Hammersmith Hospital, London, in adult cardiology and at Great Ormond Street Hospital, London in Paediatric Cardiology. He is currently Professor of Cardiology at The Heart Hospital, as well as at Great Ormond Street Hospital and is British Heart Foundation Professor of Cardiology at University College London.
Professor Deanfield’s main clinical interests are paediatric cardiology / adult congenital heart disease (covering the whole age range of patients born with congenital heart disease), and cardiovascular disease prevention. He has been clinical and academic head of the cardiothoracic unit at Great Ormond Street Hospital and established the adolescent transition clinic, as well as the adult congenital heart disease centre at The Heart Hospital London. This is now one of the largest in Europe. He has developed specialist programs for management of arrhythmia, heart failure and cardiac catheterisation.
His other main clinical interest is in the prevention of cardiovascular disease. He has developed strategies for lifetime management of cardiovascular risk and factors such as, hypertension, diabetes and obesity. He has chaired the Joint British Society’s national guidelines on cardiovascular disease risk factor management. Professor Deanfield has written many papers on these subjects, lectures extensively both nationally and internationally and runs a large practice in both congenital heart disease and in preventative cardiology, privately as well as in the NHS.
Royal Brompton Hospital, London, UK
Dr Alexander Lyon studied medicine at Oxford University where he was awarded a first-class degree in physiological sciences in 1995, achieving second place in the final honours school. After qualifying from the John Radcliffe Medical School in 1998, he trained as a junior doctor in cardiology in Oxford, London (Royal Brompton Hospital) and Sydney, Australia.
He joined the cardiac medicine research group of Professor Sian Harding and Professor Philip Poole-Wilson, where he studied the influence of cardiac gene therapy upon ventricular arrhythmia generation. He was awarded an MRC Clinical Research Training Fellowship in 2005 and completed his PhD in 2008, where he spent his first postdoctoral year studying the spatiotemporal patterns of mitochondrial function in the lab of Fadi Akar and Roger Hajjar at Mount Sinai School of Medicine, New York.
He was appointed a Walport Clinical Lecturer in Cardiology at Imperial College in October 2008, and he completed his cardiology training at St Mary’s Hospital and Royal Brompton Hospital.
He was appointed a senior lecturer and consultant cardiologist at Royal Brompton Hospital in January 2012.
Department of Internal Medicine and Cardiology, Saarland University Hospital, Homburg, Germany
Dr Felix Mahfoud studied medicine at the Johann-Wolfgang-Goethe University, Frankfurt, Germany. He completed his residency at the Department of Internal Medicine and Cardiology, Angiology and Intensive Care Medicine, Saarland University Hospital, Homburg, Germany. He is currently associate professor and senior physician of Internal Medicine and Cardiology at Saarland University Hospital and Affiliate/Visiting Professor of the Harvard-MIT, Biomedical Engineering, Boston, MA. Dr Mahfoud has board certifications in internal medicine, cardiology, intensive care medicine, and hypertension. He is a recipient of multiple national and international awards. His special scientific interest includes pathophysiology, conservative and novel interventional therapies of hypertension and heart failure. He is member of several editorial boards and serves as board member of the European Society of Cardiology Council on Hypertension‚ Vice-Chair of the Working Group Interventional Hypertension Treatment of the European Society of Hypertension, EuroPCR Board of Directors, Co-Chairmen of the Resistant Hypertension Course, and program committee member of the ESC congress 2017 & 2018. Dr Mahfoud is involved as steering committee member in the design and execution of several pharmaceutical and interventional studies in hypertension treatment.
Department of Internal Medicine, Robert Bosch Hospital Stuttgart, Germany
1969 – 1975 Electrical engineering studies at TU Hannover, Diploma 1975, academic title “Diplom-Ingenieur”
1975 – 1981 Medical studies (Medizinische Hochschule Hannover, Glasgow University, University of Cologne)
1981 State graduation examination in Medicine1983Academic title “Dr. med.” with the thesis “Long term results after gastrectomy”
1989 Habilitation for Internal Medicine with the thesis “Evaluation of cardiac function using magnetic resonance imaging”
1997 Associate Professor of Medicine and Cardiology, University of Cologne
1988 Board examination in Internal Medicine
1990 Board examination in Cardiology
1982 – 1985 Residency, Department of Internal Medicine, University of Aachen
1985 – 1986 Fellow in cardiac MRI, Department of Radiology, UCSF
1987 – 1989 Residency, Department of Internal Medicine, University of Cologne
1995 Assistant Professor of Medicine and Cardiology, Klinik III für Innere Medizin, University of Cologne; investigator in clinical studies
Since 1997 Chief of Cardiology, Robert Bosch Hospital Stuttgart
Since 1998 Associate Professor of Medicine and Cardiology, University of Tübingen
Key research areas
Functional coronary artery disease
Magnetic resonance imaging
Coronary computed tomography
St. George’s University, London, UK
Sanjay Sharma is Professor of Cardiology and Head of Research for the clinical and academic group at St George’s University of London and St George’s NHS Foundation trust. His interests, sudden cardiac death in the young, heart muscle disease and cardiovascular adaptation in athletes for which he has an international reputation and has over 220 PubMed citations. He regularly lectures at major scientific meetings and is now considered as one of the most prolific cardiologist in the world in his field of research.
Professor Sharma leads a large tertiary inherited cardiac diseases program serving South East England to manage young patients with cardiomyopathy and ion channel diseases. He is the director for the largest sports cardiology unit in the UK which is responsible athletes with potentially serious cardiac diseases from the British premier soccer and rugby league, Lawn Tennis association and the English institute of sport. He is the cardiology advisor for the British rowing team, Sky cycling squad and is the chairman for the expert cardiac committee for the football association. He is medical director of the London marathon and has been commended for providing one of the best medical services for endurance events in the world. Based on this reputation, he was appointed as the lead cardiologist for the 2012 London Olympics. Professor Sharma was chairman of the ESC sports cardiology nucleus and congress programme committee member of the European Society of Cardiology in Preventive Cardiology.
Working with the charitable organisation, Cardiac Risk in the Young (CRY) for the past 20 years, Professor Sharma leads the largest cardiac screening programme in the UK for individuals aged 14-35 years old. The charity screens over 20,000 individuals each year from which several data sets have been developed to provide an estimate of the number of young individuals dying suddenly from unsuspected heart disease and methods to prevent such tragedies. With CRY, he lobbied hard in Parliament and was contributed to chapter 8 of the National Service Framework in cardiology which is committed to cardiac disease in the young and a significantly large proportion of his research has been dedicated to saving young lives in the UK.
Professor Sharma enjoys teaching under graduates and post graduates and has written several educational books including the Rapid Review of Medicine, which is the most popular book in the work for passing the MRCP part 2 examination.
3rd Division of Cardiology, Medical University of Silesia, Katowice, Poland
King’s College London, King’s College Hospital, London, UK
In 2004 Professor Wendler was appointed at King’s College Hospital, and held the position of clinical director for cardiovascular services from 2006 until 2012, when he was promoted Professor of Cardiac Surgery at King’s College London.
Professor Wendler has a particular interests in the treatment of heart valve disease and is sub-specialised in valve repair techniques including the aortic root, mitral and tricuspid valve. Due to his particular expertise in this area, Professor Wendler runs a service particularly specialised in the treatment of complex multiple heart valve surgery including patients with carcinoid disease. Through his close collaboration with the vascular surgical department and interventional radiology he has also established King’s College Hospital as one of the major centers for thoracic aortic surgery.
In 2007 Professor Wendler performed the first transapical Transcatheter Aortic Valve Implantation (TAVI) in the UK and has established King’s College Hospital as one of the major international centers for this innovative treatment. Over recent years the King’s Heart Team performed the first TAVI in a failing aortic bioprosthesis (2008), the first transcatheter valve implantation in a failing mitral bioprosthesis (2010) and the worlds first non-predilation transapical TAVI in 2011.
Most recent developments of the King’s Heart Team focus on patients with ischemic cardiomyopathy and the treatment of patients with functional mitral regurgitation as a result of left ventricular dysfunction. The first minimal invasive surgery on a patient with a left ventricular aneurysm using the LIVE (Less Invasive Ventricular Enhancement) procedure was performed at King’s in 2013 and new minimally invasive treatment for mitral regurgitation is awaited soon.
Jose L. Zamorano
Department of Cardiology, University Hospital Ramón y Cajal, Madrid, Spain
1987 Medical Doctor, University Complutense, Madrid
1991 Doctor in Medicine – Cum Laude
1993 Specialist in Cardiology
1998 Assoc. Prof. of Medicine
2006 Management and Health resources (ESADE business school Madrid)
2007 Professor of Cardiology
Positions ESC and other professional organisations
1990 – 2002 President, Working Group on Non-invasive Diagnostic Imaging, Spanish Society of Cardiology
2001 – 2004 Member, Scientific Committee, European Association of Echocardiography of the European Society of Cardiology
since 2003 Member, Accreditation Committee, European Association of Echocardiography
2004 – 2008 Member, Guidelines Committee of the ESC
2006 – 2008 Member of the Board – Councillor European Society of Cardiology
2006 – 2008 President Elect European Association of Echocardiography of the ESC
since 2007 ACC International Advisor in the International Committee
2008 – 2010 Secretary of the European Society of Cardiology
2008 – 2010 President European Association of Echocardiography of the ESC
since 2012 Chair of the ESC Guidelines Committee
since 2013 President of Spanish National Research Evaluation Committee
Major research interest
Ischaemic heart disease
CV Risk factors
CV Imaging modalities